Universitätsspital Zürich (USZ)

EANO–EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma (2019) Franceschi E, Hofer S, Brandes AA, Frappaz D, Kortmann RD, Bromberg J, Dangouloff-Ros V, et al. Journal article, Review article Harmonization and standardization of panel-based tumour mutational burden (TMB) measurement: Real-world results and recommendations of the QuIP study (2019) Stenzinger A, Endris V, Budczies J, Merkelbach-Bruse S, Dietmaier W, Siebolts U, Maas J, et al. Conference contribution Translational Highlights in Breast and Ovarian Cancer 2019 – Immunotherapy, DNA Repair, PI3K Inhibition and CDK4/6 Therapy (2019) Hartkopf AD, Mueller V, Woeckel A, Lux MP, Janni W, Ettl J, Belleville E, et al. Journal article, Review article S-layer protein-AuNP systems for the colorimetric detection of metal and metalloid ions in water (2019) Jung J, Lakatos M, Bengs S, Matys S, Raff J, Blueher A, Cuniberti G Journal article Regulation of Fibroblast Apoptosis and Proliferation by MicroRNA-125b in Systemic Sclerosis (2019) Kozlova A, Pachera E, Maurer B, Juengel A, Distler J, Kania G, Distler O Journal article Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities (2019) Reinhardt A, Stichel D, Schrimpf D, Koelsche C, Wefers AK, Ebrahimi A, Sievers P, et al. Journal article Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease by Use of Mycophenolate at Baseline: Subgroup Analysis of the SENSCIS Trial (2019) Highland K, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, et al. Conference contribution Effect of Anti-Topoisomerase I Antibody Status on Decline in Lung Function in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Data from the SENSCIS Trial (2019) Mayes M, Highland K, Gahlemann M, Fischer A, Raghu G, Girard M, Alves M, et al. Conference contribution The INBUILD Trial of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases: Subgroup with Autoimmune Diseases (2019) Matteson E, Kelly C, Distler J, Mann-Vold AMH, Seibold J, Mittoo S, Distler O, et al. Conference contribution Cracking a Novel Profibrotic Molecular Mechanism: lncRNA H19X and DDIT4L Crosstalk (2019) Pachera E, Assass S, Salazar G, Frank-Bertoncelj M, Distler J, Kania G, Distler O Conference contribution